Intervention Fit Matrix is the practical layer after biomarker selection and before protocol sprawl. It helps decide which move fits the goal, which biomarkers deserve tracking, when to escalate and when to stop pretending a weak intervention is still working.
Goal to action
The matrix keeps goal, intervention, biomarkers, review window and tradeoffs in the same frame so the next escalation stays operational.
Protocol loop
Use the board to choose the signal, this matrix to pick the move, the journal to validate evidence and the analyzer to manage timing or overlap.
Scope rule
Fit lanes
Goal to intervention routes
High-evidence moves
Good default starts
Low-cost entries
Cheap before complexity
Fast review lanes
Signals that move early
Goal
Pick the real objective first: glucose stability, ApoB cleanup, sleep repair, recovery, performance or stack tolerance.
Fit
The best intervention is usually the one that can move biomarkers or support signals without opening too many variables at once.
Review
Every lane includes a review window, an escalation trigger and a withdrawal rule so the protocol does not drift into vibe-based tweaking.
Return to the board when you still need to choose the first panel and repeat cadence before touching an intervention.
Move into compounds, timing and overlap risk once the intervention lane itself is already clearer.
Use the journal when the intervention needs an evidence sanity check before you scale, combine or remove it.
Return to the homepage if you want the broader route across biomarkers, evidence and protocol decisions.
Search by goal, intervention or biomarker
Search by topic or category.
7 visible results
Glucose stability and appetite control
Energy swings, reactive hunger or first doubts around glucose tolerance.
ApoB, triglycerides and central adiposity
Weak lipid baseline, rising waistline or a first serious cardiometabolic risk block.
Short sleep and circadian drift
Fatigue that looks more like schedule and light drift than a real deficit or an insufficient stack.
Fatigue driven by real deficiency
Ferritin, B12, vitamin D or CBC suggest a real gap before adding more tools.
Poor recovery and load-driven inflammation
Persistent soreness, weak HRV, elevated resting heart rate or a clear sense of overreaching.
Strength, lean mass and performance resilience
You train seriously, food intake is reasonably stable and you want a simple intervention with a lot of evidence.
Stack tolerance and safety cleanup
There are too many new variables, strange symptoms or tolerance labs are no longer telling a clean story.
| Goal | Best-fit intervention | Biomarkers and watch signals | Escalate or retire | Tradeoffs |
|---|---|---|---|---|
| Glucose stability and appetite control Energy swings, reactive hunger or first doubts around glucose tolerance. | Meal architecture plus post-meal walking Review window: 2-4 weeks for daily pattern; 12 weeks for HbA1c |
| Escalate if: CGM variability stays high, insulin remains elevated or HbA1c does not improve after a full window. Retire if: There is no measurable shift despite good adherence or the rule creates more friction than real benefit. | Cost Low Friction Low-mid Evidence High Timing Fast It is one of the cheapest and most useful starts, but it needs consistency and at least a minimal log instead of more gadgets. |
| ApoB, triglycerides and central adiposity Weak lipid baseline, rising waistline or a first serious cardiometabolic risk block. | Soluble fiber plus calorie environment cleanup Review window: 8-12 weeks with bodyweight and diet relatively stable |
| Escalate if: ApoB or triglycerides stay clearly off, waist does not move or family history suggests diet alone will not be enough. Retire if: Digestive tolerance drops, adherence collapses or biomarkers were already reasonable and the real focus was elsewhere. | Cost Low-medium Friction Medium Evidence High Timing Medium A very strong first lever before expanding supplements, but it competes with social life, food environment and daily adherence. |
| Short sleep and circadian drift Fatigue that looks more like schedule and light drift than a real deficit or an insufficient stack. | Morning light plus a fixed sleep window Review window: 2-3 weeks for routine signal; 4-6 weeks to see metabolic spillover |
| Escalate if: HRV stays depressed, resting heart rate remains high or glucose worsens despite a better routine. Retire if: The schedule structure is not viable or it adds more stress than it removes. | Cost Low Friction Mid-high Evidence High Timing Fast It has very high upside and almost no monetary cost, but it demands social discipline and quickly unravels when the schedule breaks. |
| Fatigue driven by real deficiency Ferritin, B12, vitamin D or CBC suggest a real gap before adding more tools. | Targeted repletion after baseline Review window: 8-12 weeks before repeating labs and deciding again |
| Escalate if: Markers stay low, absorption looks doubtful or symptoms continue despite well-executed repletion. Retire if: Markers have normalized and symptoms do not move, or overshooting risk starts to appear. | Cost Medium Friction Low-mid Evidence Mid-high Timing Medium It works very well when the deficit is real, but it is a weak move when fatigue is mostly sleep, load or stress. |
| Poor recovery and load-driven inflammation Persistent soreness, weak HRV, elevated resting heart rate or a clear sense of overreaching. | Deload plus a recovery hygiene block Review window: 2-6 weeks depending on overload depth |
| Escalate if: CRP stays high, HRV does not recover or fatigue persists despite lower load and cleaner sleep. Retire if: Performance drops without signal relief or there was never a clear overload story supporting this route. | Cost Low Friction Medium Evidence Medium Timing Fast-medium It is often necessary before adding more things, but psychologically it is hard because it feels like doing less to improve more. |
| Strength, lean mass and performance resilience You train seriously, food intake is reasonably stable and you want a simple intervention with a lot of evidence. | Creatine plus useful protein distribution Review window: 6-8 weeks to read performance, tolerance and comparable labs |
| Escalate if: Strength still stalls, total protein stays low or recovery does not improve despite good adherence. Retire if: Digestive discomfort appears, water retention does not feel worth it or kidney labs drift without a benign explanation. | Cost Low Friction Low Evidence High Timing Medium Excellent evidence-to-cost ratio, but it requires interpreting creatinine in training context so tolerance is not misread. |
| Stack tolerance and safety cleanup There are too many new variables, strange symptoms or tolerance labs are no longer telling a clean story. | Simplification or a short washout Review window: 4-8 weeks with fewer variables and an honest comparison |
| Escalate if: Enzymes stay off, symptoms persist or too many compounds were layered too quickly. Retire if: Labs normalize, the main suspect is already identified or simplification does not uncover useful signal. | Cost Low Friction Mid-high Evidence Medium Timing Medium It is the right move when uncertainty is high, but it loses value if you are not willing to remove variables for real. |
Glucose stability and appetite control
Best when: Energy swings, reactive hunger or first doubts around glucose tolerance.
Review window: 2-4 weeks for daily pattern; 12 weeks for HbA1c
Watch signals
Escalate if: CGM variability stays high, insulin remains elevated or HbA1c does not improve after a full window.
Retire if: There is no measurable shift despite good adherence or the rule creates more friction than real benefit.
Tradeoff: It is one of the cheapest and most useful starts, but it needs consistency and at least a minimal log instead of more gadgets.
ApoB, triglycerides and central adiposity
Best when: Weak lipid baseline, rising waistline or a first serious cardiometabolic risk block.
Review window: 8-12 weeks with bodyweight and diet relatively stable
Watch signals
Escalate if: ApoB or triglycerides stay clearly off, waist does not move or family history suggests diet alone will not be enough.
Retire if: Digestive tolerance drops, adherence collapses or biomarkers were already reasonable and the real focus was elsewhere.
Tradeoff: A very strong first lever before expanding supplements, but it competes with social life, food environment and daily adherence.
Short sleep and circadian drift
Best when: Fatigue that looks more like schedule and light drift than a real deficit or an insufficient stack.
Review window: 2-3 weeks for routine signal; 4-6 weeks to see metabolic spillover
Watch signals
Escalate if: HRV stays depressed, resting heart rate remains high or glucose worsens despite a better routine.
Retire if: The schedule structure is not viable or it adds more stress than it removes.
Tradeoff: It has very high upside and almost no monetary cost, but it demands social discipline and quickly unravels when the schedule breaks.
Fatigue driven by real deficiency
Best when: Ferritin, B12, vitamin D or CBC suggest a real gap before adding more tools.
Review window: 8-12 weeks before repeating labs and deciding again
Watch signals
Escalate if: Markers stay low, absorption looks doubtful or symptoms continue despite well-executed repletion.
Retire if: Markers have normalized and symptoms do not move, or overshooting risk starts to appear.
Tradeoff: It works very well when the deficit is real, but it is a weak move when fatigue is mostly sleep, load or stress.
Poor recovery and load-driven inflammation
Best when: Persistent soreness, weak HRV, elevated resting heart rate or a clear sense of overreaching.
Review window: 2-6 weeks depending on overload depth
Watch signals
Escalate if: CRP stays high, HRV does not recover or fatigue persists despite lower load and cleaner sleep.
Retire if: Performance drops without signal relief or there was never a clear overload story supporting this route.
Tradeoff: It is often necessary before adding more things, but psychologically it is hard because it feels like doing less to improve more.
Strength, lean mass and performance resilience
Best when: You train seriously, food intake is reasonably stable and you want a simple intervention with a lot of evidence.
Review window: 6-8 weeks to read performance, tolerance and comparable labs
Watch signals
Escalate if: Strength still stalls, total protein stays low or recovery does not improve despite good adherence.
Retire if: Digestive discomfort appears, water retention does not feel worth it or kidney labs drift without a benign explanation.
Tradeoff: Excellent evidence-to-cost ratio, but it requires interpreting creatinine in training context so tolerance is not misread.
Stack tolerance and safety cleanup
Best when: There are too many new variables, strange symptoms or tolerance labs are no longer telling a clean story.
Review window: 4-8 weeks with fewer variables and an honest comparison
Watch signals
Escalate if: Enzymes stay off, symptoms persist or too many compounds were layered too quickly.
Retire if: Labs normalize, the main suspect is already identified or simplification does not uncover useful signal.
Tradeoff: It is the right move when uncertainty is high, but it loses value if you are not willing to remove variables for real.